title: Bioengineering organized, multilamellar human corneal stromal tissue by growth factor supplementation on highly aligned synthetic substrates.
abstract: Recapitulating the microstructure of the native human corneal stromal tissue is believed to be a key feature in successfully engineering the corneal tissue. The stratified multilayered collagen fibril lamellae with orthogonal orientation determine the robust biomechanical properties of this tissue, and the uniform collagen fibril size and interfibrillar spacing are critical to its optical transparency. The objective of this investigation was to develop a highly organized collagen-fibril construct secreted by human corneal stromal stem cells (hCSSCs) to mimic the human corneal stromal tissue. In culture on a highly aligned fibrous substrate made from poly(ester urethane) urea, the fibroblast growth factor-2 (FGF-2, 10 ng/mL) and transforming growth factor-beta 3 (TGF-β3, 0.1 ng/mL) impacted the organization and abundance of the secreted collagen fibril matrix. hCSSCs differentiated into keratocytes with significant upregulation of the typical gene markers, including KERA, B3GnT7, and CHST6. FGF-2 treatment stimulated hCSSCs to secrete collagen fibrils strongly aligned in a single direction, whereas TGF-β3 induced collagenous layers with orthogonal fibril orientation. The combination of FGF-2 and TGF-β3 induced multilayered lamellae with orthogonally oriented collagen fibrils, in a pattern mimicking the human corneal stromal tissue. The constructs were 60-70 μm thick and had an increased content of cornea-specific extracellular matrix components, including keratan sulfate, lumican, and keratocan. The approach of combining substrate cues with growth factor augmentation offers a new means to engineer well-organized, collagen-based constructs with an appropriate nanoscale structure for corneal repair and regeneration.
authors.affiliation: Department of Surgery, McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15204, USA.
authors.forename: Jian
authors.initials: J
authors.lastname: Wu
authors.forename: Yiqin
authors.initials: Y
authors.lastname: Du
authors.forename: Mary M
authors.initials: MM
authors.lastname: Mann
authors.forename: Enzhi
authors.initials: E
authors.lastname: Yang
authors.forename: James L
authors.initials: JL
authors.lastname: Funderburgh
authors.forename: William R
authors.initials: WR
authors.lastname: Wagner
mesh_terms: D057005:Bioengineering / Q000379:methods*; D002478:Cells, Cultured; D003319:Corneal Stroma / Q000166:cytology*; D016222:Fibroblast Growth Factor 2 / Q000737:chemistry / Q000494:pharmacology; D006801:Humans; D013234:Stem Cells / Q000166:cytology / Q000187:drug effects; D023822:Tissue Engineering / Q000379:methods*; D053782:Transforming Growth Factor beta3 / Q000737:chemistry / Q000494:pharmacology*
chemical_list: D053782:Transforming Growth Factor beta3; D016222:Fibroblast Growth Factor 2
references.citation: Ocul Surf. 2003 Apr;1(2):53-65
references.pmid: 17075633
references.citation: J Cell Biochem. 2009 Oct 1;108(2):476-88
references.pmid: 19626665
references.citation: Am J Pathol. 2003 Dec;163(6):2459-76
references.pmid: 14633618
references.citation: PLoS One. 2012;7(3):e33163
references.pmid: 22479366
references.citation: J Biol Chem. 2003 Nov 14;278(46):45629-37
references.pmid: 12933807
references.citation: Invest Ophthalmol Vis Sci. 2009 Sep;50(9):4155-61
references.pmid: 19387067
references.citation: J Biol Chem. 2001 Nov 23;276(47):44173-8
references.pmid: 11555658
references.citation: Invest Ophthalmol Vis Sci. 1993 Jun;34(7):2316-24
references.pmid: 7685009
references.citation: Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1382-8
references.pmid: 19875671
references.citation: Exp Cell Res. 1994 Oct;214(2):621-33
references.pmid: 7523155
references.citation: J Opt Soc Am. 1969 Jun;59(6):766-74
references.pmid: 5805456
references.citation: Cornea. 1996 Sep;15(5):505-16
references.pmid: 8862928
references.citation: Ophthalmology. 2009 Dec;116(12):2354-60
references.pmid: 19815285
references.citation: Science. 1999 Dec 10;286(5447):2169-72
references.pmid: 10591651
references.citation: Nat Biotechnol. 2003 Nov;21(11):1369-77
references.pmid: 14595365
references.citation: Calcif Tissue Int. 2009 Jul;85(1):66-74
references.pmid: 19424740
references.citation: Appl Opt. 1971 Mar 1;10(3):459-73
references.pmid: 20094474
references.citation: Biophys J. 2005 Feb;88(2):1377-86
references.pmid: 15533922
references.citation: World J Gastroenterol. 2007 Jun 14;13(22):3056-62
references.pmid: 17589920
references.citation: Dev Growth Differ. 2012 Apr;54(3):327-40
references.pmid: 22524604
references.citation: J Biol Chem. 2000 May 5;275(18):13918-23
references.pmid: 10788517
references.citation: J Tissue Eng Regen Med. 2011 Aug;5(8):e228-38
references.pmid: 21604386
references.citation: Cornea. 1997 Mar;16(2):177-87
references.pmid: 9071531
references.citation: Mol Vis. 2010 Dec 10;16:2680-9
references.pmid: 21179234
references.citation: Stem Cells. 2012 Jun;30(6):1059-63
references.pmid: 22489057
references.citation: J Biomed Opt. 2004 Mar-Apr;9(2):259-64
references.pmid: 15065889
references.citation: Micron. 2001 Apr;32(3):223-37
references.pmid: 11006503
references.citation: J Cell Sci. 1990 Apr;95 ( Pt 4):649-57
references.pmid: 2384532
references.citation: Curr Eye Res. 1998 Mar;17(3):286-93
references.pmid: 9543637
references.citation: Tissue Cell. 2013 Feb;45(1):68-76
references.pmid: 23122986
references.citation: J Physiol. 1957 Apr 30;136(2):263-86
references.pmid: 13429485
references.citation: Biomaterials. 2012 Feb;33(5):1343-52
references.pmid: 22078813
references.citation: Bull World Health Organ. 2001;79(3):214-21
references.pmid: 11285665
references.citation: Front Biosci (Landmark Ed). 2009 Jan 01;14:3326-37
references.pmid: 19273277
references.citation: Invest Ophthalmol Vis Sci. 2001 Oct;42(11):2490-5
references.pmid: 11581188
references.citation: Biotechnol Lett. 2011 Oct;33(10):2091-101
references.pmid: 21660579
references.citation: Cornea. 1996 Sep;15(5):525-32
references.pmid: 8862930
references.citation: Invest Ophthalmol Vis Sci. 2007 Nov;48(11):5038-45
references.pmid: 17962455
references.citation: Sci Transl Med. 2010 Aug 25;2(46):46ra61
references.pmid: 20739681
references.citation: Mol Vis. 2008 Feb 09;14:308-17
references.pmid: 18334944
references.citation: Invest Ophthalmol Vis Sci. 1989 Mar;30(3):435-42
references.pmid: 2925315
references.citation: Invest Ophthalmol Vis Sci. 1998 Sep;39(10):1957-64
references.pmid: 9727420
references.citation: Stem Cells. 2005 Oct;23(9):1266-75
references.pmid: 16051989
references.citation: Glia. 1998 Jan;22(1):19-30
references.pmid: 9436785
references.citation: Histol Histopathol. 2009 Nov;24(11):1405-16
references.pmid: 19760590
references.citation: Dev Dyn. 2008 Oct;237(10):2705-15
references.pmid: 18624285
references.citation: J Biomed Mater Res A. 2010 Sep 1;94(3):978-87
references.pmid: 20730935
references.citation: Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3128-36
references.pmid: 19234354
references.citation: Int J Biochem Cell Biol. 2011 Jun;43(6):928-35
references.pmid: 21421073
references.citation: Invest Ophthalmol Vis Sci. 2007 Sep;48(9):4050-60
references.pmid: 17724187
references.citation: Invest Ophthalmol Vis Sci. 2011 Nov 21;52(12):8957-64
references.pmid: 22025571
references.citation: Nat Rev Immunol. 2002 Nov;2(11):872-80
references.pmid: 12415310